Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma
Alessandra Scagliola(University of Milan), Stefano Biffo(University of Milan), Nicola Manfrini(University of Milan), Gabriele Ventura(University of Milan), Marco Maggioni(University of Milan), Annarita Miluzio(Istituto Nazionale Genetica Molecolare), Luca Valenti(University of Milan), Guido Baselli(Science for Life Laboratory), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Chiara Cordiglieri(Istituto Nazionale Genetica Molecolare), Daniela Brina(Institute of Oncology Research), Alberto Bresciani(University of Bergamo), Sara Ricciardi(Vita-Salute San Raffaele University), Delia Cirino(University of Milan), Stefania Oliveto(Istituto Nazionale Genetica Molecolare)
Cited by 39
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789